Immunohistochemical detection of advanced glycation end products in human bladder with specific monoclonal antibody

International Journal of Urology

Volumn 16, Issue 4, 2009, Pages 402-405

  Matsumoto, Kenshi ^a   Fujiwara, Yukio ^a   Nagai, Ryoji ^a   Yoshida, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Human bladder; Macrophage; Oxidation

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; IMIDAZOLONE; MONOCLONAL ANTIBODY; PENTOSIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER; BLADDER CANCER; CLINICAL ARTICLE; CYSTECTOMY; DRUG ACCUMULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MACROPHAGE; MALE; PRIORITY JOURNAL; TISSUE SECTION;

EID: 64549129997     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02259.x     Document Type: Article

References (25)

1. Monnier VM. Toward a Maillard reaction theory of aging. In : Baynes JW, Monnier VM (eds). The Maillard Reaction in Aging, Diabetes, and Nutrition. Alan R. Liss, New York, 1989 1 22.
2. Thornalley PJ. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol. Biol 1998 44 : 1013 23.
3. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J. Biol. Chem. 1992 267 : 10 211 14.
4. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. J. Biol. Chem. 1989 264 : 21 597 602.
5. Konishi Y, Hayase F, Kato H. Novel imidazolone compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in proteins. Biosci. Biotech. Biochem. 1994 58 : 1953 5.
6. Monnier VM, Sell DR, Nagaraja RH et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging and uremia. Diabetes 1992 41 (Suppl 36 41.
7. Kume S, Takeya M, Mori T et al. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 1995 147 : 654 67.
8. Kume S, Kato S, Yamagishi S et al. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J. Bone Miner. Res. 2005 20 : 1647 58.
9. 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J. Clin. Invest. 1993 92 : 1243 52.
10. Ohgami N, Nagai R, Miyazaki A et al. Scavenger receptor class B Type I-mediated reverse cholesterol transport inhibited by advanced glycation end products. J. Biol. Chem. 2001 276 : 13 348 55.
11. Seftel AD, Vaziri D, Ni Z et al. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997 50 : 1016 26.
12. Ikeda K, Higashi T, Sano H et al. Nε-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996 35 : 8075 83.
13. Jono T, Kimura T, Takamatsu J et al. Accumulation of imidazolone, pentosidine and Nε-(Carboxymethyl)lysine in hippocampal neurons of aged human brain. Pathol. Int. 2002 52 : 563 71.
14. Newman I, Wikinson PC. Methods for phenotyping polarized and locomotor human lymphocytes. J. Immunol. Methods 1992 147 : 42 50.
15. Hayase F, Shibuya T, Sato J, Yamamoto M. Effects of oxygen and transition metals on advanced Maillard reaction of proteins with glucose. Biosci. Biotech. Biochem. 1996 60 : 1820 5.
16. Nagai R, Araki T, Hayashi CM, Hayase F, Horiuchi S. Identification of N(varepsilon)-(carboxyethyl)lysine, one of the methylglyoxal-derived AGE structures, in glucose-modified protein: mechanism for protein modification by reactive aldehydes. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003 788 : 75 84.
17. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in autoxidative modification of protein by glucose. Biochemistry 1995 34 : 3702 9.
18. Li YM, Mitsuhashi T, Wojciechowicz D et al. Molecular identity and cellular distribution of advanced glycation endproduct receptors: Relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl Acad. Sci. USA 1996 93 : 11 047 52.
19. Neeper M, Schmidt AM, Brett J et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992 267 : 14 998 5004.
20. Araki N, Higashi T, Mori T et al. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur. J. Biochem. 1995 230 : 408 15.
21. Ohgami N, Nagai R, Ikemoto M et al. CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products. J. Biol. Chem. 2001 276 : 3195 202.
22. Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett. 2002 511 : 170 4.
23. Suzuki H, Kurihara Y, Takeya M et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997 386 : 292 6.
24. Biwa T, Hakamata H, Sakai M et al. Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor. J. Biol. Chem. 1998 273 : 28 305 13.
25. Lee WC, Chien CT, Yu HJ, Lee SW. Bladder dysfunction in rats with metabolic syndrome induced by long-term fructose feeding. J. Urol. 2008 179 : 2470 6.